Hospital Pharmacy Europe
AUGUST 14, 2023
A significant and increasing trend towards the use of a three-month rather than six-month adjuvant chemotherapy regime in stage 3 colon cancer has been observed following publications from the IDEA collaboration abstract. In addition, CAPOX prescribing also significantly increased from 14% to 48% (p <0.001).
European Pharmaceutical Review
JULY 5, 2022
The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. Benefits of daily oral chemotherapy over IV.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 19, 2022
EQRx’s GEMSTONE-302 study evaluated the efficacy and safety of the investigational anti-PD-L1 antibody, sugemalimab, in combination with chemotherapy as a first-line treatment for patients with stage four non-small cell lung cancer (NSCLC), versus using chemotherapy alone. But prevalence still increased by 10% between 2008 and 2012.
European Pharmaceutical Review
JULY 26, 2022
The committee has recommended that Rubraca (rucaparib camsylate) should no longer be used as third-line treatment for cancers of the ovary, fallopian tubes or peritoneum with a BRCA mutation in patients whose cancer has come back after at least two platinum-based chemotherapies and who cannot have further platinum-based therapy.
Blog: Ask a Student Pharmacist
JUNE 21, 2023
Antimicrobial agents and chemotherapy. Antimicrobial agents and chemotherapy. Antiviral chemistry & chemotherapy. 2004; 19(3):275-8. 2004; 60(10):2187-21900. Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac Laurent , Kim B, Patterson SE, Mansky LM. 2016; 60(4):2318-25. Retrovirology.
The Checkup by Singlecare
OCTOBER 16, 2023
Food and Drug Administration (FDA) in 2004 , Cymbalta has become a widely used antidepressant to treat various mental health and pain-related conditions. Chemotherapy-Induced Peripheral Neuropathy Studies have shown that duloxetine may help prevent or reduce nerve pain in people who have been treated with chemotherapy.
The Checkup by Singlecare
JANUARY 23, 2024
It is known as an antineoplastic (chemotherapy) agent, a disease-modifying antirheumatic drug ( DMARD ), and an immunosuppressant agent. Methotrexate has distinct mechanisms of action for its use as chemotherapy versus immunosuppression in autoimmune diseases.
Expert insights. Personalized for you.
97 
Let's personalize your content